The high IFN in the peripheral circulation of SLE patients could promote pulmonary vascular cells to release IP10 and ET-1, lead to an imbalance between vasoconstriction and vasodilatation factors. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.